etoposide has been researched along with Hematologic Neoplasms in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (12.73) | 18.2507 |
| 2000's | 23 (41.82) | 29.6817 |
| 2010's | 19 (34.55) | 24.3611 |
| 2020's | 6 (10.91) | 2.80 |
| Authors | Studies |
|---|---|
| Ballestrero, A; Bello, C; Cea, M; Cirmena, G; Dal Bello, G; Duchosal, MA; Dupuis, M; Fruscione, F; Garuti, A; Grossi, F; Moran, E; Nahimana, A; Nencioni, A; Patrone, F; Pronzato, P; Rocco, I; Sordat, B; Vogel, P | 1 |
| Burroni, B; Chapuis, N; Charpentier, J; Decroocq, J; Le Stang, V; Péju, E; Pène, F; Vigneron, C | 1 |
| Gong, Y; Wang, B; Wu, Q; Yang, H; Yang, L; Zhong, X | 1 |
| Abdulhaq, H; Baweja, A; Brem, EA; Daniel, CE; Gaut, D; Lee, M; Ly, J; Oliai, C; Othman, T; Penaloza, J; Pinter-Brown, L; Reid, J; Tuscano, J; Zhang, S | 1 |
| Adachi, H; Atsuta, Y; Doki, N; Hashimoto, S; Igarashi, A; Kaito, S; Kishida, Y; Kito, S; Kobayashi, T; Konishi, T; Konuma, R; Marumo, A; Mukae, J; Murofushi, KN; Nagata, A; Najima, Y; Noguchi, Y; Ogawa, H; Ohashi, K; Shimizu, H; Shingai, N; Toya, T; Wada, A; Yamada, Y | 1 |
| Dowling, M; Grigg, A; Janson, B; Khot, A; Siderov, J; Stewart, T; Xie, J | 1 |
| Attenberger, U; Brossart, P; Garbe, S; Heine, A; Holderried, T; Kersting, L; Koch, D; Köksal, M; Leitzen, C; Sarria, GR; Scafa, D; Schmeel, LC; Schoroth, F; Zoga, E | 1 |
| Bleckmann, K; Borkhardt, A; Bronsema, A; Burkhardt, B; Chen-Santel, C; Debatin, KM; Ebinger, M; Eckert, C; Escherich, G; Klingebiel, T; Kolb, R; Koscielniak, E; Kuhlen, M; Möricke, A; Queudeville, M; Rossig, C; Schrappe, M; Vieth, S; von Stackelberg, A; Vonalt, A; Zwaan, CM | 1 |
| Barnoud, D; Barthélémy, C; Béné, J; Bruno, B; Décaudin, B; Gautier, S; Lahoche, A; Odou, P; Petitpain, N; Pinçon, C; Simon, N; Vasseur, M | 1 |
| Arnall, JR; Moore, DC; Plesca, DC | 1 |
| Sato, S; Tamai, Y; Tanaka, E | 1 |
| Bal, C; Gulbas, Z; Ozkan, HA | 1 |
| Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A | 1 |
| Chen, YB; Gu, SL; Li, LJ; Lv, T; Shen, P; Wei, ZQ; Zhang, XW | 1 |
| Ford, PA; Grant, SJ; Keck, G; Mick, R | 1 |
| Aquino, V; Duerst, R; Graham, M; Moore, T; Morris, C; Morris, J; Neudorf, S; Olsson, B; Rudebeck, M; Shah, AJ | 1 |
| Chiba, S; Kanda, Y; Kurokawa, M; Motokura, T; Nannya, Y; Oshima, K; Sakata-Yanagimoto, M; Takahashi, T; Yoshimi, A | 1 |
| Han, XH; He, XH; Li, B; Liu, P; Shi, YK; Yang, JL; Yang, S; Zhang, CG; Zhou, SY | 1 |
| Abdelhaleem, M; Benseler, S; Gupta, AA; Tyrrell, P; Valani, R; Weitzman, S | 1 |
| Chen, ZC; Li, L; Li, QB; Xia, LH; You, Y; Zou, P | 1 |
| Chao, NJ; Chino, JP; Craciunescu, O; Folz, RJ; Horwitz, ME; Kelsey, CR; Marks, LB; Rizzieri, DA; Steffey, B | 1 |
| Andresen, S; Askar, M; Bolwell, BJ; Copelan, E; Dean, R; Kalaycio, M; Macklis, R; Pohlman, B; Rybicki, L; Serafin, M; Serafino, S; Sobecks, RM | 1 |
| Choma, M; Chybicka, A; Cornish, J; Gorczyńska, E; Grund, G; Kowalczyk, JR; Peters, C; Sykora, KW; Wachowiak, J | 1 |
| Bhojwani, D; Campana, D; Cheng, C; Howard, SC; Inaba, H; Jeha, S; Leung, W; Metzger, ML; Pauley, JL; Pei, D; Pui, CH; Ribeiro, RC; Rubnitz, JE; Sandlund, JT | 1 |
| Baumgart, M; Bertsch, HP; Haase, D; Kaune, KM; Mitteldorf, C; Neumann, C; Rosenwald, A; Schön, MP; Wulf, G | 1 |
| Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ | 1 |
| Ali, Z; Dada, MO; Flowers, CR; Graiser, M; Hutcherson, DA; McMillan, S; Waller, EK; Zhang, H | 1 |
| Bauer, K; Engert, A; Hübel, K; Monsef, I; Rancea, M; Skoetz, N | 1 |
| Hong, M; Li, JY; Liu, P; Lu, H; Qian, SX; Qiu, HX; Shen, WY; Wu, HX; Xu, W; Zhang, R | 1 |
| Davies, JH; Evans, BA; Gregory, JW; Jenney, ME | 1 |
| Cavenagh, J; Chopra, R; Clark, FJ; Culligan, D; Davies, A; Fuller, S; Hunt, L; Hunter, A; Littlewood, T; Lush, R; Marks, DI; Marsh, J; Milligan, DW; Parker, A; Schey, S; Smith, GM; Towlson, K; Vandenberghe, E; Williams, CD; Yin, J | 1 |
| Andresen, S; Bernhard, L; Bolwell, BJ; Kalaycio, M; Kohuth, J; Kuczkowski, E; Lomax, R; Mendiola, S; Pohlman, B; Rybicki, L; Sobecks, R | 1 |
| Bentley, S; Brecher, ME; Bruner, R; Capel, E; Dent, G; Gabriel, DA; Moore, DT; Sailer, S; Serody, JS; Shea, TC; Wiley, JM | 1 |
| Asaka, M; Chiba, K; Hashino, S; Imamura, M; Izumiyama, K; Kahata, K; Kato, N; Kobayashi, S; Kondo, T; Miura, Y; Mori, A; Ota, S; Tanaka, J; Toubai, T; Toyoshima, N; Yonezumi, M | 1 |
| Sonis, ST | 1 |
| Ault, K; Case, D; Damon, L; Linker, C; Martin, T; Navarro, W; Ries, C; Rugo, H; Tolaney, S | 1 |
| Bohlius, J; Engert, A; Hülsewede, H; Kober, T | 1 |
| Ge, Z; Hong, M; Li, JY; Liu, P; Lu, H; Qian, SX; Wu, HX; Wu, YJ; Zhang, R; Zhang, XY | 1 |
| Einhorn, LH; Papiani, G | 1 |
| Inoue, M; Kawa, K; Koyama, M; Sawada, A; Yasui, M | 1 |
| Ager, S; Baglin, TP; Barker, P; Bass, G; Bloxham, DM; Boraks, PA; Hood, IM; Jestice, HK; Johnson, D; Mahendra, P; Marcus, RE; Scott, MA | 1 |
| Agaliotis, DP; Ballester, OF; Elfenbein, GJ; Fields, KK; Goldstein, SC; Hiemenz, JW; Janssen, WE; Perkins, JB; Zorksy, PE | 1 |
| Gaarsdal, E; Jensen, L; Johnsen, HE; Knudsen, LM; Nielsen, KJ; Nikolaisen, K | 1 |
| Amylon, MD; Blume, KG; Chao, NJ; Forman, SJ; Hoppe, RT; Hu, WW; Long, GD; Nademanee, AP; Negrin, RS; Niland, J; Reichardt, VL; Snyder, DS; Stockerl-Goldstein, KE; Vora, N; Wong, R | 1 |
| Barbui, T; Bassan, R; Chiodini, B; Cornelli, PE; Cortelazzo, S; Lerede, T; Zucchetti, M | 1 |
| Fukuda, H; Kunitoh, H; Saijo, N; Sekine, I | 1 |
| Ohnishi, K | 1 |
| Alessandrino, EP; Bernasconi, C; Bernasconi, P; Caldera, D; Colombo, A; Klersy, C; Malcovati, L; Martinelli, G; Nascimbene, C; Varettoni, M; Vitulo, P; Volpini, E | 1 |
| Berger, HM; Dürken, M; Finckh, B; Fischer, R; Herrnring, C; Kohlschütter, A; Kohlschütter, B; Moison, RM; Nagel, S; Nielsen, P; Pichlmeier, U; Zander, AR | 1 |
| Daugherty, CK; Hallahan, DE; Laport, GF; Larson, RA; Sobecks, RM; Wagner, ND | 1 |
| Aranha, FJ; De Souza, CA; Lima Filho, EC; Lorand-Metze, I; Marques, JF; Miranda, EC; Santini, G; Valbonesi, M; Vigorito, AC | 1 |
| Greco, FA; Hainsworth, JD | 1 |
| Aulagner, G; Bertrand, Y; Bleyzac, N; Dai, Q; Galambrun, C; Janoly, A; Jelliffe, RW; Magron, P; Maire, P; Martin, P; Souillet, G | 1 |
| Björkholm, M; Liliemark, E; Liliemark, J; Osby, E | 1 |
| Herrera, P; Jodra, MH; Laraña, JG; López, J; Navarro, JL; Odriozola, J; Pérez de Oteyza, J; Ramos, ML; Ramos, P; Roldán, E; Villalón, L; Zamora, C | 1 |
7 review(s) available for etoposide and Hematologic Neoplasms
| Article | Year |
|---|---|
Pneumatosis cystoides intestinalis associated with etoposide in hematological malignancies: a case report and a literature review.
Topics: Conservative Treatment; Etoposide; Hematologic Neoplasms; Humans; Pneumatosis Cystoides Intestinalis; Tomography, X-Ray Computed | 2022 |
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophosphamide; Dacarbazine; Disseminated Intravascular Coagulation; Doxorubicin; Etoposide; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Prednisone; Procarbazine; Purpura, Thrombocytopenic, Idiopathic; Randomized Controlled Trials as Topic; Receptors, Thrombopoietin; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Viral Vaccines | 2012 |
Fourth biannual report of the Cochrane Haematological Malignancies Group.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Europe; Hematologic Neoplasms; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Meta-Analysis as Topic; Multicenter Studies as Topic; Multiple Myeloma; National Institutes of Health (U.S.); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Pyrazines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Transplantation, Autologous; United States; Vinblastine; Vincristine | 2006 |
Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
Topics: Adolescent; Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Movement; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Kidney Diseases; Leukapheresis; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Podophyllotoxin; Retrospective Studies; Thiotepa; Transplantation Conditioning | 1996 |
Cancer chemotherapy in the elderly.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Busulfan; Daunorubicin; Doxorubicin; Etoposide; Female; Fluorouracil; Heart; Hematologic Neoplasms; Humans; Lung; Male; Middle Aged; Neoplasms; Pyrazoles | 1998 |
[Oral antitumor drugs for hematological malignancies].
Topics: Administration, Oral; Antineoplastic Agents; Cytarabine; Etoposide; Hematologic Neoplasms; Humans; Hydroxyurea; Leukemia-Lymphoma, Adult T-Cell; Piperazines; Prodrugs; Tretinoin | 1999 |
Germ cell neoplasms and other malignancies of the mediastinum.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Bleomycin; Carcinoma; Child; Cisplatin; Combined Modality Therapy; Etoposide; Genetic Predisposition to Disease; Germinoma; Hematologic Neoplasms; Humans; Incidence; Klinefelter Syndrome; Lymphoma, Non-Hodgkin; Mediastinal Neoplasms; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Nerve Tissue; Radiotherapy, Adjuvant; Seminoma; Treatment Outcome | 2001 |
13 trial(s) available for etoposide and Hematologic Neoplasms
| Article | Year |
|---|---|
Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapy.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Neurotoxicity Syndromes; Retrospective Studies; T-Lymphocytes | 2017 |
Safety, Pharmacokinetics, and Efficacy of Palifermin in Children and Adolescents with Acute Leukemias Undergoing Myeloablative Therapy and Allogeneic Hematopoietic Stem Cell Transplantation: A Pediatric Blood and Marrow Transplant Consortium Trial.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Fibroblast Growth Factor 7; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia; Male; Myeloablative Agonists; Stomatitis; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2016 |
Multiple unit umbilical cord blood transplantation with total body irradiation, etoposide and antithymocyte globulin for adult haematological malignancy patients.
Topics: Adolescent; Adult; Antilymphocyte Serum; Cord Blood Stem Cell Transplantation; Etoposide; Female; Hematologic Neoplasms; Histocompatibility; Humans; Male; Middle Aged; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation; Young Adult | 2011 |
Treosulfan-based preparative regimens for allo-HSCT in childhood hematological malignancies: a retrospective study on behalf of the EBMT pediatric diseases working party.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematologic Neoplasms; Humans; Infant; Male; Melphalan; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2011 |
[Clinical study on high-dose etoposide with granulocyte colony-stimulating factor for mobilization of autologous peripheral blood stem cells in patients with hematologic malignancies].
Topics: Adolescent; Adult; Aged; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Young Adult | 2012 |
An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Radiotherapy, Adjuvant; Time Factors; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2003 |
Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Double-Blind Method; Etoposide; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Mouth Mucosa; Radiation Injuries; Severity of Illness Index; Stomatitis; Treatment Outcome; Whole-Body Irradiation | 2005 |
Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
Topics: Adolescent; Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carmustine; Cell Movement; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Kidney Diseases; Leukapheresis; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Podophyllotoxin; Retrospective Studies; Thiotepa; Transplantation Conditioning | 1996 |
Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Life Tables; Lung Diseases, Interstitial; Male; Middle Aged; Neutropenia; Remission Induction; Treatment Outcome | 1996 |
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Male; Middle Aged; Whole-Body Irradiation | 1997 |
Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Hematologic Neoplasms; Humans; Idarubicin; Lymphoproliferative Disorders; Male; Middle Aged | 1998 |
Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infections; Lung Diseases; Male; Melphalan; Middle Aged; Retrospective Studies; Transplantation, Autologous | 2000 |
Oral etoposide in patients with hematological malignancies: a clinical and pharmacokinetic study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Area Under Curve; Etoposide; Hematologic Neoplasms; Humans; Middle Aged; Palliative Care; Survival Analysis | 2001 |
36 other study(ies) available for etoposide and Hematologic Neoplasms
| Article | Year |
|---|---|
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.
Topics: alpha-Mannosidase; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Hematologic Neoplasms; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Teprotide | 2010 |
Etoposide-containing regimens for the treatment of critically ill patients with hematological malignancy-related hemophagocytic lymphohistiocytosis.
Topics: Critical Illness; Etoposide; Hematologic Neoplasms; Humans; Lymphohistiocytosis, Hemophagocytic; Retrospective Studies | 2022 |
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Hematologic Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab; Vincristine | 2022 |
Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study.
Topics: Cyclophosphamide; Cytarabine; Etoposide; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Neoplasm Recurrence, Local; Prospective Studies; Radiotherapy, Intensity-Modulated; Retrospective Studies; Transplantation Conditioning; Whole-Body Irradiation | 2022 |
Acute kidney injury in patients receiving high-dose etoposide phosphate as conditioning prior to hematopoietic stem cell transplantation in hematologic malignancies may be associated with elevated body mass index.
Topics: Acute Kidney Injury; Body Mass Index; Etoposide; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Transplantation Conditioning | 2023 |
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy.
Topics: Bone Marrow; Carmustine; Etoposide; Hematologic Neoplasms; Humans; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Whole-Body Irradiation | 2023 |
Acute kidney injury after high dose etoposide phosphate: A retrospective study in children receiving an allogeneic hematopoetic stem cell transplantation.
Topics: Acute Kidney Injury; Antineoplastic Agents; Child; Etoposide; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Organophosphorus Compounds; Prognosis; Retrospective Studies; Survival Rate; Transplantation Conditioning | 2018 |
Transitioning historically inpatient chemotherapy regimens for hematologic malignancies to the ambulatory care setting.
Topics: Ambulatory Care; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Hematologic Neoplasms; Hospitalization; Humans; Prednisone; Vincristine | 2018 |
Blastic plasmacytoid dendritic cell neoplasm with response to pralatrexate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dendritic Cells; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Hematologic Neoplasms; Humans; Ifosfamide; Male; Prednisone; Skin Neoplasms; Vincristine | 2019 |
Assessment and comparison of acute cardiac toxicity during high-dose cyclophosphamide and high-dose etoposide stem cell mobilization regimens with N-terminal pro-B-type natriuretic peptide.
Topics: Adult; Aged; Antineoplastic Agents; Cardiotoxicity; Cyclophosphamide; Etoposide; Female; Heart; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Risk; ROC Curve; Time Factors; Treatment Outcome; Young Adult | 2014 |
Sixteenth biannual report of the Cochrane Haematological Malignancies Group: focus on Non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Boronic Acids; Bortezomib; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematologic Neoplasms; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Melphalan; Nitriles; Nitrogen Mustard Compounds; Prednisone; Primary Myelofibrosis; Pyrazines; Pyrazoles; Pyrimidines; Quality of Life; Randomized Controlled Trials as Topic; Rituximab; Vincristine | 2014 |
Risk factors, outcomes and epidemiology associated with Clostridium difficile infection in patients with haematological malignancies in a tertiary care hospital in China.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Antineoplastic Agents, Phytogenic; China; Clostridioides difficile; Clostridium Infections; Cross Infection; Enterocolitis, Pseudomembranous; Etoposide; Feces; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Multilocus Sequence Typing; Retrospective Studies; Ribotyping; Risk Factors; Tertiary Care Centers; Young Adult | 2015 |
Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses.
Topics: Adult; Aged; Aminocaproic Acid; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Carmustine; Combined Modality Therapy; Cyclophosphamide; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hemoglobins; Humans; Iron; Jehovah's Witnesses; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Recurrence; Stem Cell Transplantation; Transplantation, Autologous; Vitamin K 1; Young Adult | 2015 |
A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: reduced cyclophosphamide combined with etoposide and total body irradiation.
Topics: Adolescent; Adult; Combined Modality Therapy; Comorbidity; Cyclophosphamide; Etoposide; Female; Heart Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Myeloablative Agonists; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2008 |
Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity.
Topics: Adolescent; Adult; Antigens, CD34; Child; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Male; Middle Aged; Neutropenia; Thrombocytopenia; Transplantation Conditioning; Treatment Outcome; Vomiting | 2009 |
Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Topics: Adolescent; Adrenal Cortex Hormones; Cause of Death; Child; Child, Preschool; Cyclosporine; Etoposide; Female; Hematologic Neoplasms; Humans; Immunoglobulins, Intravenous; Infant; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Male; Retrospective Studies; Rheumatic Diseases; Steroids; Virus Diseases | 2009 |
A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Aspergillus; Busulfan; China; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Idarubicin; Immunosuppressive Agents; Leukemia; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Mucositis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Premedication; Retrospective Studies; Risk Factors; Semustine; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2009 |
Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors.
Topics: Acute Disease; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Lung; Male; Melphalan; Middle Aged; Pneumonia; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation; Young Adult | 2011 |
Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies.
Topics: Adenine Nucleotides; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Etoposide; Female; Hematologic Neoplasms; Humans; Infant; Male | 2012 |
Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; CD56 Antigen; Chromosomes, Human, Pair 11; Cyclophosphamide; Dendritic Cells; Doxorubicin; Etoposide; Fatal Outcome; Hematologic Neoplasms; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Male; Neoplasm Recurrence, Local; Prednisolone; Skin; Skin Neoplasms; Transplantation, Homologous; Vincristine | 2011 |
[Acquired ichthyosis and haematological malignancies: five cases].
Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematologic Neoplasms; Hodgkin Disease; Humans; Ichthyosis; Imatinib Mesylate; Leukemia, Myeloid, Accelerated Phase; Lung Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Parotid Neoplasms; Piperazines; Platelet Aggregation Inhibitors; Prednisone; Procarbazine; Pyrimidines; Retrospective Studies; Rituximab; Schizophrenia; Stomach Neoplasms; Vincristine | 2012 |
Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cohort Studies; Cyclophosphamide; Drug Administration Routes; Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous | 2012 |
In vitro effects of combination chemotherapy on osteoblasts: implications for osteopenia in childhood malignancy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Diseases, Metabolic; Child; Daunorubicin; Etoposide; Female; Glucocorticoids; Hematologic Neoplasms; Humans; Osteoblasts; Stem Cells; Tumor Cells, Cultured; Vincristine | 2002 |
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Cyclosporine; Cytarabine; Data Collection; Etoposide; Female; Follow-Up Studies; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2002 |
A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation.
Topics: Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mouth Mucosa; Multivariate Analysis; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Stomatitis; Transplantation, Autologous | 2002 |
Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Bone Marrow Transplantation; Cause of Death; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Remission Induction; Retrospective Studies; Safety; Survival Rate; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2004 |
Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Filgrastim; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Mucositis; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Transplantation Conditioning; Transplantation, Autologous; Tumor Burden | 2006 |
[High-dose etoposide with granulocyte colony-stimulating factor for mobilization of autologous peripheral blood stem/progenitor cells in patients with hematologic malignancies].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Transplantation, Homologous | 2006 |
Salvage chemotherapy with high-dose carboplatin plus etoposide and autologous peripheral blood stem cell transplant in male pure choriocarcinoma: a retrospective analysis of 13 cases.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Choriocarcinoma, Non-gestational; Chorionic Gonadotropin; Disease-Free Survival; Etoposide; Hematologic Neoplasms; Humans; Male; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Time Factors; Transplantation, Autologous; Ultrasonography | 2007 |
Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Epstein-Barr Virus Infections; Etoposide; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Lymphohistiocytosis, Hemophagocytic; Male; Remission Induction; Transplantation, Homologous | 2007 |
Improved priming for mobilization of and optimal timing for harvest of peripheral blood stem cells.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Blood Transfusion, Autologous; Bone Marrow; Carmustine; Cyclophosphamide; Cytarabine; Drug Administration Schedule; Drug Synergism; Epirubicin; Etoposide; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cells; Humans; Injections, Subcutaneous; Leukapheresis; Leukocyte Count; Male; Melphalan; Middle Aged; Neoplasms; Recombinant Proteins | 1996 |
Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation.
Topics: Allantoin; Antineoplastic Agents; Antioxidants; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Etoposide; Fatty Acids, Unsaturated; Hematologic Neoplasms; Humans; Iron; Lipid Peroxides; Oxidative Stress; Reactive Oxygen Species; Statistics, Nonparametric; Ubiquinone; Uric Acid; Whole-Body Irradiation | 2000 |
A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.
Topics: Adult; Blood Platelets; Cohort Studies; Combined Modality Therapy; Etoposide; Female; Graft Survival; Graft vs Host Disease; Heart Failure; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Lung; Lung Diseases; Male; Middle Aged; Mouth Mucosa; Neutrophils; Recurrence; Stomatitis; Survival; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2000 |
Early total white blood cell recovery is a predictor of low number of apheresis and good CD34(+) cell yield.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Caspase 14; Caspases; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Infection Control; Leukapheresis; Leukocyte Count; Leukocytes, Mononuclear; Male; Middle Aged; Recombinant Proteins; Time Factors | 2000 |
Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens.
Topics: Adolescent; Alkylating Agents; Area Under Curve; Bayes Theorem; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Genetic Diseases, Inborn; Graft Survival; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Humans; Incidence; Infant; Life Tables; Male; Melphalan; Prospective Studies; Severe Combined Immunodeficiency; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2001 |
Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment.
Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Caspase 14; Caspases; Cerebral Hemorrhage; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Erythropoietin; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infections; Leukapheresis; Life Tables; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Transplantation Conditioning; Transplantation, Autologous | 2000 |